0001209191-19-005451.txt : 20190125 0001209191-19-005451.hdr.sgml : 20190125 20190125204422 ACCESSION NUMBER: 0001209191-19-005451 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190124 FILED AS OF DATE: 20190125 DATE AS OF CHANGE: 20190125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Freve Jonathan CENTRAL INDEX KEY: 0001664466 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37718 FILM NUMBER: 19543701 MAIL ADDRESS: STREET 1: C/O SPRING BANK PHARMACEUTICALS, INC. STREET 2: 113 CEDAR STREET, STE S-7 CITY: MILFORD STATE: MA ZIP: 01757 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Spring Bank Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001566373 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 522386345 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 PARKWOOD DRIVE STREET 2: SUITE 210 CITY: HOPKINTON STATE: MA ZIP: 01748 BUSINESS PHONE: 508-473-5993 X119 MAIL ADDRESS: STREET 1: 35 PARKWOOD DRIVE STREET 2: SUITE 210 CITY: HOPKINTON STATE: MA ZIP: 01748 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-01-24 0 0001566373 Spring Bank Pharmaceuticals, Inc. SBPH 0001664466 Freve Jonathan C/O SPRING BANK PHARMACEUTICALS, INC. 35 PARKWOOD DRIVE HOPKINTON MA 01748 0 1 0 0 CFO & Treasurer Stock Option (Right to Buy) 10.35 2019-01-24 4 A 0 50000 0.00 A 2029-01-24 Common Stock 50000 50000 D This option was granted on January 24, 2019, with 25% of the shares subject to the option vesting on January 24, 2020 and the remaining 75% of the shares subject to the option vesting in 36 equal monthly installments thereafter. /s/ Lori Firmani, Attorney-in-Fact 2019-01-25